Bulletin de Périodique
International Journal of Drug Policy , Vol.39 - January 2017
Paru le :
01/01/2017
Année :
2017
Page(s) :
1-145
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Pathways through opiate use and offending: A systematic review. Hayhurst K.P., Pierce M., Hickman M., Seddon T., Dunn G., Keane J., et al., p. 1-13.
- Young people and injection drug use: Is there a need to expand harm reduction services and support? Adamson K., Jackson L., Gahagan J., p. 14-20.
- Injection-site vein loss and soft tissue abscesses associated with black tar heroin injection: A cross-sectional study of two distinct populations in USA. Summers P.J., Struve I.A., Wilkes M.S., Rees V.W., p. 21-27.
- Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective. Apud I., Romaní O., p. 28-36.
- Factors associated with syphilis seroreactivity among polydrug users in Northeast Brazil: A cross-sectional study using Respondent Driven Sampling. Baptista C.J., Dourado I., Brignol S., Andrade T.d.M., Bastos F.I., p. 37-42.
- Maritime transportation of illegal drugs from South America. Atkinson M.P., Kress M., Szechtman R., p. 43-51.
- Creating visual differences: Methamphetamine users perceptions of anti-meth campaigns. Marsh W., Copes H., Linnemann T., p. 52-61.
- Non-medical use of prescription drugs among illicit drug users: A case study on an online drug forum. Rönkä S., Katainen A., p. 62-68.
- Drug use in business bathrooms: An exploratory study of manager encounters in New York City. Wolfson-Stofko B., Bennett A.S., Elliott L., Curtis R., p. 69-77.
- Exploring the social lives of image and performance enhancing drugs: An online ethnography of the Zyzz fandom of recreational bodybuilders. Underwood M., p. 78-85.
- Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). Carrieri P., Vilotitch A., Nordmann S., Lions C., Michel L., Mora M., et al., p. 86-91.
- "We're giving you something so we get something in return": Perspectives on research participation and compensation among people living with HIV who use drugs. Collins A.B., Strike C., Guta A., Baltzer Turje R., McDougall P., Parashar S., et al., p. 92-98.
- Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England. Kesten J.M., Ayres R., Neale J., Clark J., Vickerman P., Hickman M., et al., p. 99-108.
- Rethinking retention in treatment of opioid dependence - The eye of the beholder. Vogel M., Dürsteler K.M., Walter M., Herdener M., Nordt C., p. 109-113.
- Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs. Walley A.Y., Cheng D.M., Quinn E.K., Blokhina E., Gnatienko N., Chaisson C.E., et al., p. 114-120.
- Drug decriminalization and the price of illicit drugs. Félix S., Portugal P., p. 121-129.
- Reasons for missed appointments with a hepatitis C outreach clinic: A qualitative study. Poll R., Allmark P., Tod A.M., p. 130-137.
- Alprazolam in fatal overdose following regulatory rescheduling: A response to Deacon et al. Lloyd B., Dwyer J., Bugeja L., Jamieson A., p. 138-139.
- Transitions at the International Journal of Drug Policy [Editorial]. Rhodes T., p. 141-142.
- My time with the International Journal of Drug Policy [Editorial]. Stimson G.V., p. 143-145.
- Pathways through opiate use and offending: A systematic review. Hayhurst K.P., Pierce M., Hickman M., Seddon T., Dunn G., Keane J., et al., p. 1-13.
- Young people and injection drug use: Is there a need to expand harm reduction services and support? Adamson K., Jackson L., Gahagan J., p. 14-20.
- Injection-site vein loss and soft tissue abscesses associated with black tar heroin injection: A cross-sectional study of two distinct populations in USA. Summers P.J., Struve I.A., Wilkes M.S., Rees V.W., p. 21-27.
- Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective. Apud I., Romaní O., p. 28-36.
- Factors associated with syphilis seroreactivity among polydrug users in Northeast Brazil: A cross-sectional study using Respondent Driven Sampling. Baptista C.J., Dourado I., Brignol S., Andrade T.d.M., Bastos F.I., p. 37-42.
- Maritime transportation of illegal drugs from South America. Atkinson M.P., Kress M., Szechtman R., p. 43-51.
- Creating visual differences: Methamphetamine users perceptions of anti-meth campaigns. Marsh W., Copes H., Linnemann T., p. 52-61.
- Non-medical use of prescription drugs among illicit drug users: A case study on an online drug forum. Rönkä S., Katainen A., p. 62-68.
- Drug use in business bathrooms: An exploratory study of manager encounters in New York City. Wolfson-Stofko B., Bennett A.S., Elliott L., Curtis R., p. 69-77.
- Exploring the social lives of image and performance enhancing drugs: An online ethnography of the Zyzz fandom of recreational bodybuilders. Underwood M., p. 78-85.
- Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). Carrieri P., Vilotitch A., Nordmann S., Lions C., Michel L., Mora M., et al., p. 86-91.
- "We're giving you something so we get something in return": Perspectives on research participation and compensation among people living with HIV who use drugs. Collins A.B., Strike C., Guta A., Baltzer Turje R., McDougall P., Parashar S., et al., p. 92-98.
- Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England. Kesten J.M., Ayres R., Neale J., Clark J., Vickerman P., Hickman M., et al., p. 99-108.
- Rethinking retention in treatment of opioid dependence - The eye of the beholder. Vogel M., Dürsteler K.M., Walter M., Herdener M., Nordt C., p. 109-113.
- Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs. Walley A.Y., Cheng D.M., Quinn E.K., Blokhina E., Gnatienko N., Chaisson C.E., et al., p. 114-120.
- Drug decriminalization and the price of illicit drugs. Félix S., Portugal P., p. 121-129.
- Reasons for missed appointments with a hepatitis C outreach clinic: A qualitative study. Poll R., Allmark P., Tod A.M., p. 130-137.
- Alprazolam in fatal overdose following regulatory rescheduling: A response to Deacon et al. Lloyd B., Dwyer J., Bugeja L., Jamieson A., p. 138-139.
- Transitions at the International Journal of Drug Policy [Editorial]. Rhodes T., p. 141-142.
- My time with the International Journal of Drug Policy [Editorial]. Stimson G.V., p. 143-145.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté

K. P. HAYHURST ;
M. PIERCE ;
M. HICKMAN ;
T. SEDDON ;
G. DUNN ;
J. KEANE ;
T. MILLAR
|
2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Background: Although evidence points to a strong link between illicit drug use and crime, robust evidence for temporal order in the relationship is scant. We carried out a systematic review to assess the evidence for pathways through opiate/crac[...]
Nouveauté

K. ADAMSON ;
L. JACKSON ;
J. GAHAGAN
|
2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
A complex array of intersecting social contextual factors are known to influence safer and/or unsafe practices among people who inject drugs. However, less is known about the social contextual factors that may specifically influence injection pr[...]
Nouveauté
M. P. ATKINSON ;
M. KRESS ;
R. SZECHTMAN
|
2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Background: The US invests considerable effort in searching and interdicting drug-trafficking vessels in the Caribbean and Eastern Pacific regions. While some vessels are indeed interdicted, resulting in confiscation of substantial quantities of[...]
Nouveauté

P. CARRIERI ;
A. VILOTITCH ;
S. NORDMANN ;
C. LIONS ;
L. MICHEL ;
M. MORA ;
A. MOREL ;
G. MARADAN ;
B. SPIRE ;
P. ROUX
|
2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Background: Patients receiving buprenorphine who are poor responders can continue to commit drug-related offences. Switching them from buprenorphine to methadone may result in reduced criminal behaviour. We compared self-reported offences and in[...]
Nouveauté

J. M. KESTEN ;
R. AYRES ;
J. NEALE ;
J. CLARK ;
P. VICKERMAN ;
M. HICKMAN ;
S. REDWOOD
|
2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Background: It is recommended that needle and syringe programmes (NSP) distribute low dead space syringes (LDSS) to reduce blood-borne virus transmission. We explored the acceptability of detachable LDSS among people who inject drugs (PWID) and [...]
Nouveauté
S. FELIX ;
P. PORTUGAL
|
2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Background: This study is an empirical assessment of the impact of the drug decriminalization policy followed by Portugal in July 2001, on the price of illicit drugs.
Methods: The analysis is performed using a difference-in-differences approach[...]

M. VOGEL ;
K. M. DURSTELER ;
M. WALTER ;
M. HERDENER ;
C. NORDT
|
2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : Périodique
Opioid dependence often is a chronic relapsing disorder. The evidence for medication-assisted treatment (MAT) being the treatment of first choice is unequivocal. Yet, health systems, professionals and patients often fail to offer or, respectivel[...]